TC BioPharm (Holdings) plc American Depositary Shares
TCBP
TCBP was delisted on the 21st of March, 2025.
3 hedge funds and large institutions have $166K invested in TC BioPharm (Holdings) plc American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
200% more funds holding
Funds holding: 1 → 3 (+2)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
58% less capital invested
Capital invested by funds: $399K → $166K (-$233K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
KCL Capital
New York
|
+$148K |
| 2 |
Legal & General Group
London,
United Kingdom
|
+$148K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$148K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kepos Capital
New York
|
-$264K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$32K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$30K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$25K |
| 5 |
Jane Street
New York
|
-$22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Legal & General Group
London,
United Kingdom
| $76K | +$148K | +1 | New |
|
|
KC
2
KCL Capital
New York
| $37K | +$148K | +1 | New |
|
|
WAM
3
Warberg Asset Management
Winnetka,
Illinois
| $36K | +$148K | +1 | New |
|
|
VF
4
Virtu Financial
New York
| $9K | – | – | – |
|
5
Renaissance Technologies
New York
| $8K | – | – | – |
|
|
KC
6
Kepos Capital
New York
| – | -$264K | -1 | Closed |
|
|
7
Citadel Advisors
Miami,
Florida
| – | -$32K | – | – |
|
8
Citigroup
New York
| – | -$1K | – | – |
|
|
9
Jane Street
New York
| – | -$22K | – | – |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$25K | – | – |
|
|
TSS
11
Two Sigma Securities
New York
| – | -$30K | – | – |
|
12
UBS Group
Zurich,
Switzerland
| – | -$2K | – | – |
|
TCBP Hedge Fund Activity: Q2 2022 in Review
3 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q2 2022, worth a combined $166K — down 58% from $399K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new TCBP positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was KCL Capital, opening a new position worth an estimated $148K. The largest seller was Kepos Capital, exiting entirely with an estimated $264K sold.
- 3 institutional investors held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q2 2022, up from 1 in Q1 2022.
- Funds reported $166K of TC BioPharm (Holdings) plc American Depositary Shares stock for Q2 2022, down 58% quarter-over-quarter.
- 3 funds opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q2 2022 and 1 closed out, a net change of +2 holders.
- The largest TC BioPharm (Holdings) plc American Depositary Shares buyer in Q2 2022 was KCL Capital, an estimated $148K added.
- The largest TC BioPharm (Holdings) plc American Depositary Shares seller in Q2 2022 was Kepos Capital, an estimated $264K sold.
Based on aggregated 13F filings for Q2 2022.